Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00080470 · ClinicalTrials.gov registry record · Phase 3
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
A Phase 3 study of Urinary Incontinence, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
- 11
- Study locations
NCT00080470: Completed Phase 3 study of Urinary Incontinence, sponsored by Boston Scientific Corporation.
NCT00080470 is a Phase 3 study of Urinary Incontinence that has completed, run by Boston Scientific Corporation. The registered enrollment target is 148 participants, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (43% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00080470, a Phase 3 study of Urinary Incontinence, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
- 11
- Study locations
Study Summary
This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.
Conditions Studied
Interventions
- DEVICE bion
Study Locations (11)
Texas
- Dallas Center for Pelvic Medicine - Dallas
- Baylor College of Medicine - Houston
Arizona
- Arizona Health Sciences Center (University of Arizona) - Tucson
California
- The Department of Urology, Stanford University Medical Center - Stanford
Colorado
- Milestone Medical Research - Englewood
Connecticut
- Bladder Control Center of Norwalk - Norwalk
District of Columbia
- Walter Reed Army Medical Center, Division of Pelvic Medicine and Reconstructive Surgery - Washington D.C.
Michigan
- William Beaumont Hospital - Royal Oak
Minnesota
- Cornerstone Medical Specialty Center - Woodbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2003-06 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
What the finished NCT00080470 record still lists
NCT00080470 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which bion is the first listed.
NCT00080470 lists 11 locations in 10 states (Texas, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT00080470 about?
NCT00080470 is a clinical study titled "An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence". This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.
What is the current status of trial NCT00080470?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2003-06. Estimated completion is 2012-12.
What conditions does trial NCT00080470 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT00080470?
The interventions under investigation include: bion (DEVICE).
Who is sponsoring clinical trial NCT00080470?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00080470 being conducted?
This trial has 11 study locations across Arizona, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00080470's enrollment target sits among peer trials
148 18th of 48 higher than 31 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women
COMPLETED · Phase 3
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia